Literature DB >> 3181282

Pharmacokinetics of biliary excretion in man. VI. Indocyanine green.

D K Meijer1, B Weert, G A Vermeer.   

Abstract

The pharmacokinetics of Indocyanine Green (ICG) has been studied in 15 patients given 0.5, 1.0 and 2.0 mg.kg-1. The plasma disappearance and biliary excretion rate were measured in patients with tightly fitting catheters under slight negative pressure in order to achieve complete collection of bile. Recovery of unchanged ICG in bile over 18 h after the i.v. injection was 80% of the dose in all three dose groups. Plasma disappearance in all 3 groups was biphasic, showing an initial phase with a t1/2 of 3-4 min and a secondary phase with a dose-dependent apparent t1/2 of 67.6, 72.5 and 88.7 min, respectively. After 0.5 and 1.0 mg.kg-1 the biliary excretion rate curves showed an ascending phase with a mean t1/2 of 5 min and a descending phase with a mean t1/2 of 72 min. It was inferred that the secondary component of the plasma-decay mainly reflected the biliary excretion rate. After 2.0 mg.kg-1 in some patients the biliary excretion curve showed features of saturation; the t1/2 of the descending phase ranged from 73 to 440 min, and the time of maximal excretion was increased from 1.3 to 2.7 h after injection, whilst the mean maximal excretion rate was in the same range as the excretion rate after the 1.0 mg.kg-1 dose. The non-linear pharmacokinetics was only moderately reflected in the measured plasma disappearance patterns. Two compartment analysis of the plasma levels indicated a clearance of 230-260 ml.min-1, whereas the clearance conventionally calculated from the initial t1/2 was 475 ml.min-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181282     DOI: 10.1007/bf00558268

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Hepatic handling of unconjugated dyes in the Dubin-Johnson syndrome.

Authors:  S Erlinger; D Dhumeaux; J F Desjeux; J P Benhamou
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

2.  Determination of the hepatic blood flow in man by simultaneous use of five test substances measured in two parts of the liver.

Authors:  K Winkler; J A Larsen; T Munkner; N Tygstrup
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

3.  Indocyanine green plasma clearance in normal human males and females.

Authors:  M Mikulecký
Journal:  Acta Med Acad Sci Hung       Date:  1976

4.  Nonlinear pharmacokinetics of indocyanine green in the rabbit and rat.

Authors:  K Stoeckel; P J McNamara; A J McLean; P duSouich; D Lalka; M Gibaldi
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

5.  Measurement of the association of cholephylic organic anions with different binding proteins.

Authors:  S Gentile; B L Bajema; G Baldini; G Lunazzi; G M Groothuis; C Tiribelli; D K Meijer; G L Sottocasa
Journal:  Biochem Pharmacol       Date:  1985-07-15       Impact factor: 5.858

Review 6.  Abnormal hepatic transport of indocyanine green in Gilbert's syndrome.

Authors:  J F Martin; J M Vierling; A W Wolkoff; B F Scharschmidt; J Vergalla; J G Waggoner; P D Berk
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Marked delay in indocyanine green plasma clearance with a near-normal bromosulphophthalein retention test: a constitutional abnormality?

Authors:  K Okuda; H Ohkubo; H Musha; K Kotoda; H Abe; K Tanikawa
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

8.  Physiochemical studies of indocyanine green (ICG): absorbance/concentration relationship, pH tolerance and assay precision in various solvents.

Authors:  O G Björnsson; R Murphy; V S Chadwick
Journal:  Experientia       Date:  1982-12-15

9.  Effects of caloric restriction on the kinetics of indocyanine green in patients with liver diseases and in the rat.

Authors:  H Ohkubo; H Musha; K Okuda
Journal:  Am J Dig Dis       Date:  1978-11

10.  Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

Authors:  R Heintz; C K Svensson; K Stoeckel; G J Powers; D Lalka
Journal:  J Pharm Sci       Date:  1986-04       Impact factor: 3.534

View more
  30 in total

1.  Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging.

Authors:  Christin Perlitz; Kai Licha; Frank-Detlef Scholle; Bernd Ebert; Malte Bahner; Peter Hauff; Kurt Thomas Moesta; Michael Schirner
Journal:  J Fluoresc       Date:  2005-05       Impact factor: 2.217

2.  Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green.

Authors:  Jessica A Carr; Daniel Franke; Justin R Caram; Collin F Perkinson; Mari Saif; Vasileios Askoxylakis; Meenal Datta; Dai Fukumura; Rakesh K Jain; Moungi G Bawendi; Oliver T Bruns
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-06       Impact factor: 11.205

3.  Comparative analysis of fluorescent angiography, computed tomographic angiography and magnetic resonance angiography for planning autologous breast reconstruction.

Authors:  Michael P Chae; David J Hunter-Smith; Warren Matthew Rozen
Journal:  Gland Surg       Date:  2015-04

4.  Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis.

Authors:  Didier Lebrec; Jaime Bosch; Rajiv Jalan; Francis J Dudley; Rada Jessic; Richard Moreau; Juan Carlos Garcia-Pagan; Rajeshwar P Mookerjee; Eleonora Chiossi; Paul L M Van Giersbergen; Andjela Kusic-Pajic; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2011-11-20       Impact factor: 2.953

Review 5.  Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients.

Authors:  Samir G Sakka
Journal:  J Clin Monit Comput       Date:  2017-10-16       Impact factor: 2.502

6.  Early detection of breast cancer: synthesis and characterization of novel target specific NIR-fluorescent estrogen conjugate for molecular optical imaging.

Authors:  Iven Jose; Kodand Dinakar Deodhar; Uday B Desai; Shubhadeep Bhattacharjee
Journal:  J Fluoresc       Date:  2011-01-08       Impact factor: 2.217

7.  The kinetics of continuously infused indocyanine green in the pig.

Authors:  P Ott; L Bass; S Keiding
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

8.  Hepatic drug clearance: the effect of age using indocyanine green as a model compound.

Authors:  H A Wynne; J Goudevenos; M D Rawlins; O F James; P C Adams; K W Woodhouse
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

9.  Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Authors:  P A Soons; A De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

10.  Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.

Authors:  R J MacFadyen; K R Lees; J D Gemmill; W S Hillis; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.